Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report

Area of Science:

• Allergy and Immunology
• Otolaryngology

Background:

• Allergic rhinitis affects many patients, with limited treatment options.
• Sublingual allergen immunotherapy (SLIT) presents a novel therapeutic approach.

Purpose of the Study:

• To evaluate the efficacy and safety of sublingual immunotherapy tablets for allergic rhinitis.
• To explore the potential for sustained clinical benefits after treatment cessation.

Main Methods:

• Large-scale, multicenter clinical trials were conducted.
• Efficacy and adverse events associated with SLIT tablets were assessed.

Main Results:

• SLIT tablets demonstrated established efficacy in treating allergic rhinitis.
• Common local reactions include gastrointestinal or oropharyngeal symptoms; severe anaphylaxis is rare.
• Potential for persistent clinical benefits after discontinuation of therapy.

Conclusions:

• Sublingual immunotherapy tablets are a viable option for allergic rhinitis management in the US.
• SLIT may be suitable for patients unresponsive to conventional therapies or seeking disease modification.
• The safety profile supports at-home administration, offering convenience and accessibility.